Phreesia Announces Refinancing of Bridge Loan with New $275 Million Revolving Credit Facility
Company repaid $20 million of bridge loan during fiscal fourth quarter and fully refinanced remaining balance with new long-term credit facility
ALL-REMOTE COMPANY/WILMINGTON, Del. - March 16, 2026 - Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") today announced the refinancing of its existing bridge loan (the "Bridge Loan") by its entry into a new credit agreement providing for a senior secured revolving credit facility (the "New Credit Facility") of up to $275 million in aggregate principal amount, with Capital One, National Association ("Capital One") serving as agent for the lenders. The Company borrowed approximately $92.2 million under the New Credit Facility at closing and used the proceeds to repay all outstanding indebtedness and obligations under the Bridge Loan, which was terminated without penalty. Remaining availability under the New Credit Facility may be used for working capital, capital expenditures, permitted acquisitions and other general corporate purposes.
The Bridge Loan, a 364-day $110 million secured term loan with Goldman Sachs Bank USA dated November 12, 2025, was used to fund a portion of the consideration for the acquisition of AccessOne Parent Holdings, Inc. and its subsidiaries (the "AccessOne Acquisition"). During the fiscal quarter ended January 31, 2026, the Company repaid $20 million of the outstanding principal balance of the Bridge Loan.
The New Credit Facility also replaces the Company's existing $50 million senior secured asset-based revolving credit facility with Capital One, which had no outstanding borrowings and was terminated without penalty in connection with the closing of the New Credit Facility.
"This refinancing is consistent with our stated plan to replace the bridge loan with a long-term revolving credit facility," said Chaim Indig, Phreesia's CEO and Co-Founder. "The new facility reduces our borrowing costs and enhances our longer-term financial flexibility."
For more information, please see the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 16, 2026.
About Phreesia
Phreesia is a trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 170 million patient visits in 2024-1 in 7 visits across the U.S.-scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes.
To learn more, visit phreesia.com.